title: [Neutropenia and fever in the patient with cancer].
abstract: Infection in the immunocompromised host is a serious clinical situation due to its high morbi-mortality and is one of the most frequent complications in the patient with cancer. In patients treated with chemotherapy, the risk of infection basically depends on the duration and intensity of the neutropenia. It is essential to evaluate, the most probable pathogen involved to initiate, a priori, the most suitable treatment, and also to evaluate the general clinical situation of the patient, because from the very beginning the treatment is quite aggressive. Outpatient care is possible for patients at "low risk" of complications. By evaluating the antecedents and clinical history of the patient, through physical exploration and from the data of laboratory and radiological explorations these points can be acknowledged. The early start of broad spectrum antibiotherapy is crucial, and in this chapter we review the most recent therapeutical recommendations.
authors.affiliation: Servicio de Oncología Radioterápica, Hospital de Navarra, Pamplona. seconcts@cfnavarra.es
authors.forename: A
authors.initials: A
authors.lastname: Manterola
authors.forename: P
authors.initials: P
authors.lastname: Romero
authors.forename: E
authors.initials: E
authors.lastname: Martínez
authors.forename: E
authors.initials: E
authors.lastname: Villafranca
authors.forename: F
authors.initials: F
authors.lastname: Arias
authors.forename: M A
authors.initials: MA
authors.lastname: Domínguez
authors.forename: M
authors.initials: M
authors.lastname: Martínez
mesh_terms: D002985:Clinical Protocols; D005334:Fever / Q000209:etiology* / Q000628:therapy; D006801:Humans; D007239:Infections / Q000209:etiology* / Q000628:therapy; D009369:Neoplasms / Q000150:complications*; D009503:Neutropenia / Q000209:etiology* / Q000628:therapy